This paper describes the effects of various parameters on the reduction of hematite in the presence of microwave assisted non-thermal hydrogen plasma. The parameters include microwave power, hydrogen flowrate, pressure, microwave power density and temperature. It has been shown that hydrogen flowrate, pressure and microwave power are interrelated to effect the microwave power density that controls the plasma temperature. The experimental conditions encounter three temperatures: surrounding the sample, associated with the plasma and at the plasma/substrate interface. It has been deduced that the third one is the most effective in determining the rate of the reaction, and in the present case, activation energy of 20 kJ mol 21 is reported.
There has been an increasing interest in reduction of iron ore by hydrogen. This study deals with the reduction of haematite in a microwave assisted non-thermal hydrogen plasma. The plasma is composed of excited hydrogen molecules, hydrogen atoms, and ionic hydrogen among other gaseous species. The reduction in hydrogen plasma occurred even at temperatures as low as 573 K. In contrast, the same could not be achieved by merely introducing hydrogen gas to the reducing environment without creating the plasma. It is only y1073 K that the extent of reduction by gaseous means is comparable to that of reduction by hydrogen plasma. Based on the experiments, as well as the data available from literature, it was deduced that the reduction of haematite at a low temperature in hydrogen plasma could have been due to the contribution of vibrationally excited hydrogen molecules to the reduction process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.